Exelon Corp has a consensus price target of $42.8 based on the ratings of 22 analysts. The high is $54 issued by Argus Research on June 8, 2022. The low is $36 issued by Barclays on January 22, 2024. The 3 most-recent analyst ratings were released by Barclays, Evercore ISI Group, and Scotiabank on January 22, 2025, January 21, 2025, and December 12, 2024, respectively. With an average price target of $42.67 between Barclays, Evercore ISI Group, and Scotiabank, there's an implied 6.61% upside for Exelon Corp from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Exelon (NASDAQ:EXC) was reported by Barclays on January 22, 2025. The analyst firm set a price target for $42.00 expecting EXC to rise to within 12 months (a possible 4.95% upside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for Exelon (NASDAQ:EXC) was provided by Barclays, and Exelon maintained their overweight rating.
The last upgrade for Exelon Corp happened on January 21, 2025 when Evercore ISI Group raised their price target to $44. Evercore ISI Group previously had an in-line for Exelon Corp.
The last downgrade for Exelon Corp happened on January 8, 2024 when Seaport Global changed their price target from N/A to N/A for Exelon Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelon was filed on January 22, 2025 so you should expect the next rating to be made available sometime around January 22, 2026.
While ratings are subjective and will change, the latest Exelon (EXC) rating was a maintained with a price target of $44.00 to $42.00. The current price Exelon (EXC) is trading at is $40.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.